Stock Market Volatility and Biotech Sector Response
Stock market volatility has become a recurring feature of the biotechnology investment environment, particularly as capital markets respond to shifting interest rates, clinical trial outcomes, and macroeconomic uncertainty. For biotechnology companies, whose valuations are often tied to long development timelines and regulatory milestones, market fluctuations can significantly influence financing strategy and operational planning. In 2026, … Read more